{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-23-015153","form_type":"8-K/A","ticker":null,"cik":"0001261249","company_name":"AGILE THERAPEUTICS INC","filed_at":"2023-08-22T23:59:59+00:00","discovered_at":"2026-05-14T18:03:33.383027+00:00","generated_at":"2026-06-11T05:22:14.070504+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Agile Therapeutics appoints Scott Coiante as CFO; discloses employment terms and CAO departure","bullets":["Scott Coiante appointed SVP, CFO & Treasurer effective Aug 16, 2023; base salary $430K, target bonus 45%.","Coiante receives inducement grant of 20,000 RSUs vesting over 4 years; acceleration upon change of control.","Severance: 12 months base salary (non-CoC) or 18 months lump sum plus bonus and equity acceleration (CoC).","Jason Butch separated as CAO effective Aug 15, 2023; receives 6 months base salary and benefits.","Coiante subject to 18-month non-compete and perpetual confidentiality covenants."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-23-015153","json":"https://secwatch.observer/filing/0001558370-23-015153.json","markdown":"https://secwatch.observer/filing/0001558370-23-015153.md","text":"https://secwatch.observer/filing/0001558370-23-015153.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1261249/000155837023015153/0001558370-23-015153-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1261249/000155837023015153/agrx-20230621x8ka.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-11T05:22:14.070504+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4a69112896","claim":"Jason Butch departed as Chief Accounting Officer at AGILE THERAPEUTICS INC.","evidence_excerpt":"the Company and Jason Butch came to a mutual agreement pursuant to which Mr. Butch separated from service as the Chief Accounting Officer of the Company, effective August 15, 2023","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1261249/000155837023015153/0001558370-23-015153-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"separated"},{"label":"Role","value":"Chief Accounting Officer"}],"fact_type":"executive_change"},{"claim_id":"c8edb70662","claim":"Scott Coiante was appointed as Senior Vice President, Chief Financial Officer and Treasurer at AGILE THERAPEUTICS INC.","evidence_excerpt":"appointed Scott Coiante to serve as the Company’s Senior Vice President, Chief Financial Officer and Treasurer, effective August 16, 2023","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1261249/000155837023015153/0001558370-23-015153-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Senior Vice President, Chief Financial Officer and Treasurer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}